CymaBay Therapeutics, Inc.
Treatment of intrahepatic cholestatic diseases
Last updated:
Abstract:
Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
Status:
Application
Type:
Utility
Filling date:
9 Oct 2019
Issue date:
27 Feb 2020